Flex Work policy
Corporate Policy
Full time in office
About
Capsida Biotherapeutics is a biotechnology company specialized in the development of tissue-targeted gene therapies for the treatment of multiple serious diseases, using adeno-associated virus (AAV) technology. The company was established in 2020 in partnership with Versant Ventures and Westlake Village BioPartners, with a focus on revolutionizing medicine by advancing breakthroughs in gene therapy to help millions of patients. Capsida Biotherapeutics is headquartered in Thousand Oaks, California.
This content was generated by A.I. Capsida Biotherapeutics employees can edit to make any changes.